S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
Log in

ChemoCentryx SEC Filings & 10K Form (NASDAQ:CCXI)

$7.69
-0.23 (-2.90 %)
(As of 10/23/2019 04:00 PM ET)
Today's Range
$7.62
Now: $7.69
$8.12
50-Day Range
$6.53
MA: $7.28
$8.07
52-Week Range
$6.16
Now: $7.69
$14.98
Volume273,853 shs
Average Volume460,232 shs
Market Capitalization$446.39 million
P/E RatioN/A
Dividend YieldN/A
Beta1.15

SEC Filings

ChemoCentryx (NASDAQ:CCXI) SEC Filings

DateFilerForm TypeView
10/22/2019
5:29 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
3:19 PM
ChemoCentryx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2019
3:16 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
5:17 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
3:01 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2019
8:20 PM
ChemoCentryx (Issuer)
Tyree James L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
8:10 PM
ChemoCentryx (Issuer)
Edwards Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
7:58 PM
ChemoCentryx (Issuer)
FECZKO JOSEPH M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
7:53 PM
ChemoCentryx (Issuer)
Jain Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
7:49 PM
ChemoCentryx (Issuer)
MCKINNELL HENRY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
7:42 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2019
11:15 PM
ChemoCentryx (Filer)
Form EFFECT
05/10/2019
12:40 PM
BlackRock Inc. (Filed by)
ChemoCentryx (Subject)
Form SC 13G/A
05/07/2019
2:45 PM
ChemoCentryx (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/06/2019
3:19 PM
ChemoCentryx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2019
3:16 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2019
5:46 PM
ChemoCentryx (Issuer)
SINGH RAJINDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2019
4:00 PM
BIO-TECHNE Corp (Filed by)
ChemoCentryx (Subject)
Form SC 13G/A
04/10/2019
9:34 AM
ChemoCentryx (Subject)
FMR LLC (Filed by)
Form SC 13G
04/08/2019
3:02 PM
ChemoCentryx (Filer)
Form DEF 14A
04/02/2019
6:49 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
7:08 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
7:02 PM
ChemoCentryx (Issuer)
Jain Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
6:46 PM
ChemoCentryx (Issuer)
Jain Rita (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/28/2019
12:17 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2019
4:11 PM
ChemoCentryx (Filer)
Form 8-K/A
03/11/2019
4:07 PM
ChemoCentryx (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2019
3:32 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2019
6:20 PM
ChemoCentryx (Issuer)
LUCAS ROGER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
3:32 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
8:39 PM
ChemoCentryx (Issuer)
Kwan Pui San (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
7:00 PM
ChemoCentryx (Issuer)
SINGH RAJINDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:54 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:49 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:44 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
6:14 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
3:58 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
ChemoCentryx (Subject)
Form SC 13G/A
02/13/2019
11:56 AM
ChemoCentryx (Subject)
Schall Thomas J. (Filed by)
Form SC 13G/A
02/04/2019
9:09 AM
BlackRock Inc. (Filed by)
ChemoCentryx (Subject)
Form SC 13G/A
01/30/2019
4:27 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2019
10:55 AM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2019
5:50 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
6:44 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
6:36 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
7:06 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
6:56 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
7:00 AM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2019
8:13 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
8:00 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:49 PM
ChemoCentryx (Issuer)
SINGH RAJINDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:42 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2018
4:21 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2018
4:18 PM
ChemoCentryx (Filer)
Form 424B5
11/09/2018
5:39 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2018
3:32 PM
ChemoCentryx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
3:19 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2018
6:33 AM
ChemoCentryx (Subject)
Vifor Ltd (0001675217) (Filed by)
Form SC 13D
11/02/2018
6:31 AM
ChemoCentryx (Issuer)
Vifor Ltd (0001675217) (Reporting)
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting)
Vifor Pharma Ltd. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/30/2018
5:47 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2018
5:18 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2018
4:03 PM
ChemoCentryx (Issuer)
GLAXOSMITHKLINE PLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2018
4:02 PM
ChemoCentryx (Subject)
GLAXOSMITHKLINE PLC (Filed by)
Form SC 13D/A
09/26/2018
3:04 PM
ChemoCentryx (Filer)
Form 424B5
09/18/2018
3:43 PM
ChemoCentryx (Subject)
GLAXOSMITHKLINE PLC (Filed by)
Form SC 13D/A
09/07/2018
10:59 AM
ChemoCentryx (Filer)
Form CT ORDER
08/09/2018
3:28 PM
ChemoCentryx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2018
3:19 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2018
5:50 PM
ChemoCentryx (Issuer)
Edwards Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
5:51 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2018
7:20 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2018
6:36 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2018
6:10 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2018
3:08 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2018
4:13 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
3:00 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2018
8:53 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2018
8:52 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2018
8:51 PM
ChemoCentryx (Issuer)
Tyree James L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2018
8:50 PM
ChemoCentryx (Issuer)
Parker Geoffrey M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2018
8:49 PM
ChemoCentryx (Issuer)
MCKINNELL HENRY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2018
8:48 PM
ChemoCentryx (Issuer)
LUCAS ROGER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2018
8:47 PM
ChemoCentryx (Issuer)
FECZKO JOSEPH M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2018
8:45 PM
ChemoCentryx (Issuer)
Edwards Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
6:38 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
6:34 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
6:29 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2018
6:05 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2018
3:20 PM
ChemoCentryx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2018
3:16 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2018
4:36 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2018
7:38 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2018
7:29 PM
Cappel Markus J. (Reporting)
ChemoCentryx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2018
3:03 PM
ChemoCentryx (Filer)
Form DEF 14A
03/12/2018
3:18 PM
ChemoCentryx (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/09/2018
3:01 PM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2018
7:01 AM
ChemoCentryx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2018
7:21 PM
ChemoCentryx (Issuer)
Kwan Pui San (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2018
7:09 PM
ChemoCentryx (Issuer)
Kwan Pui San (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/07/2018
7:01 PM
ChemoCentryx (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2018
6:53 PM
ChemoCentryx (Issuer)
KANAYA SUSAN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel